Rocket One Inc. Other Income and Expense
Rocket One Inc. (RKTO) reported Other Income and Expense of $149 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-14
- Rocket One Inc. nonoperating income (expense) for the quarter ending 2026-06-30 was $149.00, a 13.87% decline year-over-year.
- Rocket One Inc. nonoperating income (expense) for the quarter ending 2026-03-31 was -$44.02K, a 24418.23% decline year-over-year.
- Rocket One Inc. nonoperating income (expense) for the quarter ending 2025-12-31 was -$83.17K, a 43417.71% decline year-over-year.
- Rocket One Inc. nonoperating income (expense) for the quarter ending 2025-09-30 was -$25.14K, a 12668.50% decline year-over-year.
- Rocket One Inc. nonoperating income (expense) for fiscal 2025 was -$107.95K, a 497.88% decline from fiscal 2024.
- Rocket One Inc. nonoperating income (expense) for fiscal 2024 was $27.13K.
- Rocket One Inc. nonoperating income (expense) for fiscal 2023 was -$153.15K.
- Rocket One Inc. nonoperating income (expense) for fiscal 2022 was -$306.40K.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 8 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $149.00 10-Q · filed 2026-08-14 | -$43.87K 10-Q · filed 2026-08-14 | -$127.04K derived: sum of 3 quarters · filed 2026-08-14 | -$152.17K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$44.02K 10-Q · filed 2026-05-15 | -$127.19K derived: sum of 2 quarters · filed 2026-05-15 | -$152.32K derived: sum of 3 quarters · filed 2026-05-15 | -$152.15K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$83.17K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$108.31K derived: sum of 2 quarters · filed 2026-03-27 | -$108.13K derived: sum of 3 quarters · filed 2026-08-14 | -$107.95K 10-K · filed 2026-03-27 | |
| 2025-09-30 | -$25.14K 10-Q · filed 2025-11-12 | -$24.96K derived: sum of 2 quarters · filed 2026-08-14 | -$24.78K 10-Q · filed 2025-11-12 | -$24.59K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $173.00 10-Q · filed 2026-08-14 | $354.00 10-Q · filed 2026-08-14 | $546.00 derived: sum of 3 quarters · filed 2026-08-14 | $746.00 derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $181.00 10-Q · filed 2026-05-15 | $373.00 derived: sum of 2 quarters · filed 2026-05-15 | $573.00 derived: sum of 3 quarters · filed 2026-05-15 | $13.94K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $192.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $392.00 derived: sum of 2 quarters · filed 2026-03-27 | $13.76K derived: sum of 3 quarters · filed 2026-03-27 | $27.13K 10-K · filed 2026-03-27 | |
| 2024-09-30 | $200.00 10-Q · filed 2025-11-12 | $13.56K derived: sum of 2 quarters · filed 2025-11-12 | $26.94K 10-Q · filed 2025-11-12 | $22.49K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $13.37K 10-Q · filed 2025-08-12 | $26.74K 10-Q · filed 2025-08-12 | $22.29K derived: sum of 3 quarters · filed 2025-08-12 | $28.68K derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $13.38K 10-Q · filed 2025-05-12 | $8.92K derived: sum of 2 quarters · filed 2025-05-12 | $15.32K derived: sum of 3 quarters · filed 2025-05-12 | -$149.08K derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | -$4.45K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.94K derived: sum of 2 quarters · filed 2024-11-12 | -$162.46K derived: sum of 3 quarters · filed 2024-11-12 | -$153.15K 10-K · filed 2024-03-28 | |
| 2023-09-30 | $6.40K 10-Q · filed 2024-11-12 | -$158.00K derived: sum of 2 quarters · filed 2024-11-12 | -$148.69K 10-Q · filed 2024-11-12 | -$206.42K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$164.40K 10-Q · filed 2024-08-09 | -$155.09K 10-Q · filed 2024-08-09 | -$212.81K derived: sum of 3 quarters · filed 2024-08-09 | -$172.63K derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $9.31K 10-Q · filed 2024-05-14 | -$48.41K derived: sum of 2 quarters · filed 2024-05-14 | -$8.23K derived: sum of 3 quarters · filed 2024-05-14 | -$386.28K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$57.72K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$17.54K derived: sum of 2 quarters · filed 2024-03-28 | -$395.59K derived: sum of 3 quarters · filed 2024-03-28 | -$306.40K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $40.18K 10-Q · filed 2023-11-13 | -$337.86K derived: sum of 2 quarters · filed 2023-11-13 | -$248.68K 10-Q · filed 2023-11-13 | -$348.66K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$378.05K 10-Q · filed 2023-08-11 | -$288.86K 10-Q · filed 2023-08-11 | -$388.84K derived: sum of 3 quarters · filed 2023-08-11 | -$431.69K derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | $89.19K 10-Q · filed 2023-05-15 | -$10.79K derived: sum of 2 quarters · filed 2023-05-15 | -$53.64K derived: sum of 3 quarters · filed 2023-05-15 | -$130.50K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$99.98K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$142.83K derived: sum of 2 quarters · filed 2023-03-31 | -$219.69K derived: sum of 3 quarters · filed 2023-03-31 | -$212.26K 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$42.85K 10-Q · filed 2022-11-10 | -$119.71K derived: sum of 2 quarters · filed 2022-11-10 | -$112.29K 10-Q · filed 2022-11-10 | -$66.20K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$76.86K 10-Q · filed 2022-08-12 | -$69.43K 10-Q · filed 2022-08-12 | -$23.34K derived: sum of 3 quarters · filed 2022-08-12 | $26.56K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $7.43K 10-Q · filed 2022-05-12 | $53.52K derived: sum of 2 quarters · filed 2022-05-12 | $103.42K derived: sum of 3 quarters · filed 2022-05-12 | $121.71K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $46.09K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $96.00K derived: sum of 2 quarters · filed 2022-03-30 | $114.28K derived: sum of 3 quarters · filed 2022-03-30 | $104.16K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $49.91K 10-Q · filed 2021-11-10 | $68.19K derived: sum of 2 quarters · filed 2021-11-10 | $58.07K 10-Q · filed 2021-11-10 | $64.02K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $18.29K 10-Q · filed 2021-08-11 | $8.16K 10-Q · filed 2021-08-11 | $14.11K derived: sum of 3 quarters · filed 2021-08-11 | $18.52K derived: sum of 4 quarters · filed 2021-08-11 | |
| 2020-03-31 | -$10.13K 10-Q · filed 2021-05-13 | -$4.18K derived: sum of 2 quarters · filed 2021-05-13 | $235.00 derived: sum of 3 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $5.95K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $10.36K derived: sum of 2 quarters · filed 2021-03-16 | $10.36K 10-K · filed 2021-03-16 | ||
| 2019-09-30 | $4.41K 10-Q · filed 2020-11-10 | $4.41K 10-Q · filed 2020-11-10 | |||
| 2017-12-31 | -$144.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |